Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neoplasms.

Albero R, Enjuanes A, Demajo S, Castellano G, Pinyol M, García N, Capdevila C, Clot G, Suárez-Cisneros H, Shimada M, Karube K, López-Guerra M, Colomer D, Beà S, Martin-Subero JI, Campo E, Jares P.

J Clin Invest. 2018 Aug 31;128(9):4132-4147. doi: 10.1172/JCI96520. Epub 2018 Aug 20.

2.

Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1.

Zukerberg LR, Benedict WF, Arnold A, Dyson N, Harlow E, Harris NL.

Blood. 1996 Jul 1;88(1):268-76.

3.

AP-1 regulates cyclin D1 and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation.

Vartanian R, Masri J, Martin J, Cloninger C, Holmes B, Artinian N, Funk A, Ruegg T, Gera J.

Mol Cancer Res. 2011 Jan;9(1):115-30. doi: 10.1158/1541-7786.MCR-10-0105. Epub 2010 Dec 6.

5.

Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line.

Biliran H Jr, Wang Y, Banerjee S, Xu H, Heng H, Thakur A, Bollig A, Sarkar FH, Liao JD.

Clin Cancer Res. 2005 Aug 15;11(16):6075-86.

6.

A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma.

Beltran E, Fresquet V, Martinez-Useros J, Richter-Larrea JA, Sagardoy A, Sesma I, Almada LL, Montes-Moreno S, Siebert R, Gesk S, Calasanz MJ, Malumbres R, Rieger M, Prosper F, Lossos IS, Piris MA, Fernandez-Zapico ME, Martinez-Climent JA.

Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12461-6. doi: 10.1073/pnas.1018941108. Epub 2011 Jul 11.

7.

[Detection of cyclin D1 mRNA by reverse transcription-polymerase chain reaction in paraffin-embedded tissues and its diagnostic significance for mantle cell lymphoma].

Shui RH, Wei YK, Sun MH, Wang J, Shi DR, Zhang TM, Jin AP, Zhu XZ.

Zhonghua Bing Li Xue Za Zhi. 2005 Aug;34(8):514-8. Chinese.

PMID:
16383299
8.

Nuclear cyclin D1: an oncogenic driver in human cancer.

Kim JK, Diehl JA.

J Cell Physiol. 2009 Aug;220(2):292-6. doi: 10.1002/jcp.21791. Review.

9.

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.

Mozos A, Royo C, Hartmann E, De Jong D, Baró C, Valera A, Fu K, Weisenburger DD, Delabie J, Chuang SS, Jaffe ES, Ruiz-Marcellan C, Dave S, Rimsza L, Braziel R, Gascoyne RD, Solé F, López-Guillermo A, Colomer D, Staudt LM, Rosenwald A, Ott G, Jares P, Campo E.

Haematologica. 2009 Nov;94(11):1555-62. doi: 10.3324/haematol.2009.010264. Erratum in: Haematologica. 2010 Sep;95(9):1620.

10.
11.

Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.

Specht K, Kremer M, Müller U, Dirnhofer S, Rosemann M, Höfler H, Quintanilla-Martinez L, Fend F.

Clin Cancer Res. 2002 Sep;8(9):2902-11.

13.

GAGA factor, a positive regulator of global gene expression, modulates transcriptional pausing and organization of upstream nucleosomes.

Tsai SY, Chang YL, Swamy KB, Chiang RL, Huang DH.

Epigenetics Chromatin. 2016 Jul 27;9:32. doi: 10.1186/s13072-016-0082-4. eCollection 2016.

14.

Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels.

Rosenwald IB, Kaspar R, Rousseau D, Gehrke L, Leboulch P, Chen JJ, Schmidt EV, Sonenberg N, London IM.

J Biol Chem. 1995 Sep 8;270(36):21176-80.

15.

Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.

Fernàndez V, Hartmann E, Ott G, Campo E, Rosenwald A.

J Clin Oncol. 2005 Sep 10;23(26):6364-9. Review.

PMID:
16155021
16.

Transcriptional regulation by a DNA-associated form of cyclin D1.

Bienvenu F, Barré B, Giraud S, Avril S, Coqueret O.

Mol Biol Cell. 2005 Apr;16(4):1850-8. Epub 2005 Jan 19.

18.

The cancer/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1- and E2F-dependent manner.

Por E, Byun HJ, Lee EJ, Lim JH, Jung SY, Park I, Kim YM, Jeoung DI, Lee H.

J Biol Chem. 2010 May 7;285(19):14475-85. doi: 10.1074/jbc.M109.084400. Epub 2010 Mar 10.

19.

c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1.

Güller M, Toualbi-Abed K, Legrand A, Michel L, Mauviel A, Bernuau D, Daniel F.

World J Gastroenterol. 2008 Nov 7;14(41):6339-46.

20.

p14ARF post-transcriptional regulation of nuclear cyclin D1 in MCF-7 breast cancer cells: discrimination between a good and bad prognosis?

McGowan EM, Tran N, Alling N, Yagoub D, Sedger LM, Martiniello-Wilks R.

PLoS One. 2012;7(7):e42246. doi: 10.1371/journal.pone.0042246. Epub 2012 Jul 30.

Supplemental Content

Support Center